Nibib genotyping samples for tracking viral variants - IDIQ parent

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N92022D00016
Awardee
Awarding agency
Task orders
1 $2,480,927 obligated

Award facts

Opportunity
Combined order value
  • $2,480,927 Current, with exercised options
  • $16,697,987 Potential, with all options
Last date to order 82% complete
IDV ceiling 5% used
$47,970,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), has awarded Aegis Sciences Corporation a single-award, $47.97 million Indefinite Delivery Contract (IDC) to provide genotyping services for tracking viral variants. Task Order 001, valued at $17.77 million, has been issued under this IDC for genotyping services to be performed at Aegis' facility in Nashville, Tennessee from September 2022 to April 2024.

This contract was awarded following a sources sought notice issued by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Variant Task Force, seeking capability statements from qualified sources to potentially fulfill future sequencing support requirements. The sources sought notice did not use any set-asides. Aegis, a forensic toxicology and healthcare laboratory, was selected as the prime contractor based on its demonstrated expertise in providing COVID-19 testing, genomic sequencing, and variant tracking services to federal agencies like the NIH and Centers for Disease Control and Prevention.

Task orders

Task order Ordering agency Obligated Awarded
Nibib genotyping samples for tracking viral variants - task order 001 75N92022F00001 National Heart Lung and Blood Institute (NIH) $2,480,927

Transactions

Action Obligated Date
Other Administrative Action P00002 · The purpose of this modification is to update the program acronym to read varient task force and change the buyer to andrew dinh. $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N92022D00016?

75N92022D00016 was awarded to Aegis Sciences Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on September 28, 2022.

How much is contract 75N92022D00016 worth?

Orders under 75N92022D00016 have obligated $2,480,927. Their combined potential value, with all options, is $16,697,987. 75N92022D00016's own ceiling is $47,970,000.

How many orders have been placed under contract 75N92022D00016?

1 order has been placed under 75N92022D00016, the latest on September 28, 2022.

Who can order from contract 75N92022D00016?

75N92022D00016 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N92022D00016 competed?

The extent of competition for 75N92022D00016 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV